Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

8313	Companies
115804	Keywords
55902	Articles
62799	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 08/22/2024 at 13:00, 3 months 3 days ago

Moderna to Host Investor Event - R&D Day and Business Updates
Moderna, Inc. to host Investor Event - R&D Day and Business Updates on September 12, 2024, discussing development strategies and key considerations. Webcast available on website

Webcast MRNA Medicine Moderna Investor Event Development Strategies
BRIEF

published on 08/22/2024 at 06:05, 3 months 4 days ago

Moderna reçoit l'approbation de la FDA pour un vaccin COVID-19 mis à jour ciblant la variante KP.2

Approbation De La FDA Moderne COVID 19 Vaccin Variante KP.2
BRIEF

published on 08/22/2024 at 06:05, 3 months 4 days ago

Moderna Receives FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant

COVID-19 FDA Approval Moderna Vaccine KP.2 Variant
PRESS RELEASE

published on 08/22/2024 at 06:00, 3 months 4 days ago

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
Moderna's Spikevax 2024-2025 formula FDA-approved for individuals 12 and above to target KP.2 variant and prevent COVID-19. Availability in U.S. pharmacies imminent

COVID-19 FDA-approved Moderna Spikevax 2024-2025 Formula
BRIEF

published on 08/14/2024 at 13:05, 3 months 11 days ago

Moderna et Coursera lancent un cours gratuit sur la technologie de l'ARNm

Éducation En Ligne Technologie De L'ARNm Compétences STEM Thérapeutique Préparation De La Main-d’œuvre
BRIEF

published on 08/14/2024 at 13:05, 3 months 11 days ago

Moderna and Coursera Launch Free Course on mRNA Technology

MRNA Technology Online Education Therapeutics Workforce Readiness STEM Skills
PRESS RELEASE

published on 08/14/2024 at 13:00, 3 months 11 days ago

Moderna and Coursera Launch Free Course on mRNA Technology
Moderna and Coursera partner to offer free course 'mRNAs as Medicines' to enhance understanding of mRNA technology and its applications in medicine, supporting STEM education globally

MRNA Technology Moderna STEM Education Coursera MRNAs As Medicines
BRIEF

published on 08/01/2024 at 12:35, 3 months 24 days ago

Moderna Reports Second Quarter 2024 Financial Results and Business Updates

Financial Results Q2 2024 Moderna Vaccine MRNA
BRIEF

published on 08/01/2024 at 12:35, 3 months 24 days ago

Moderna publie ses résultats financiers et ses mises à jour pour le deuxième trimestre 2024

Résultats Financiers Moderne T2 2024 Vaccin ARNm
PRESS RELEASE

published on 08/01/2024 at 12:30, 3 months 24 days ago

Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q2 revenues of $241 million, GAAP net loss of $1.3 billion. Updates 2024 financial framework and expects product sales of $3.0-$3.5 billion. Announces key developments in vaccines and financial results

Financial Framework Moderna Business Updates Q2 Revenues Vaccine Approvals

Accesswire

Published on 11/26/2024 at 02:15, 5 hours 38 minutes ago

Alphinat Awarded Contract SSO Platform for an Ontario Municipality
Published on 11/26/2024 at 01:00, 6 hours 53 minutes ago

FE Battery Metals Corp. Commences 2024 Winter Drilling Program
Published on 11/26/2024 at 00:37, 7 hours 16 minutes ago

CORRECTION; CoTec Holdings Corp. Announces Convertible Loan Agreement
Published on 11/26/2024 at 00:20, 7 hours 33 minutes ago

NexgenRx Announces Third Quarter Results and Declaration of Divdend
Published on 11/26/2024 at 00:00, 7 hours 53 minutes ago

Medicure Reports Financial Results For Quarter Ended September 30, 2024

View all ACCESSWIRE

EQS Group

Published on 11/26/2024 at 07:30, 23 minutes ago

q.beyond intends to raise EBITDA margin to at least 10% in medium term
Published on 11/26/2024 at 07:00, 53 minutes ago

TAG receives special prize at the Real Estate Social Impact Investing Award 2024, commitment to strong neighbourhoods honoured
Published on 11/26/2024 at 06:45, 1 hour 8 minutes ago

EPIC Suisse releases high level Q3 2024 numbers in line with majority shareholder's reporting obligations
Published on 11/26/2024 at 06:45, 1 hour 8 minutes ago

mobilezone acquiert un nouveau client avec fenaco
Published on 11/25/2024 at 20:35, 11 hours 18 minutes ago

Launch of World Advanced Manufacturing & Logistics Expo & Summit (WAM Morocco) 2025 to Advance the Country’s Shift Towards Next-Generation Industries and High-Value Manufacturing

Les Echos

Published on 11/25/2024 at 18:00, 13 hours 53 minutes ago

Chiffre d’affaires consolidé 2023-2024 : 91 M€ en repli de 9,4 %
Published on 11/25/2024 at 17:55, 13 hours 58 minutes ago

Déclaration des transactions sur actions propres réalisées du 18/11/2024 au 22/11/2024
Published on 11/25/2024 at 17:55, 13 hours 58 minutes ago

Disclosure of trading in own shares from 18/11/2024 to 22/11/2024
Published on 11/25/2024 at 17:45, 14 hours 7 minutes ago

Reporting on share buyback transactions carried out between November 19 and November 22, 2024
Published on 11/25/2024 at 17:45, 14 hours 7 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 19 et le 22 novembre 2024

View all LES ECHOS COMFI WIRE